Sofiati Dian

Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial

Rovina Ruslami, Ahmad Rizal Ganiem, Sofiati Dian et al. · The Lancet Infectious Diseases · 2012 · 352 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +7

Clinical Parameters, Routine Inflammatory Markers, and LTA4H Genotype as Predictors of Mortality Among 608 Patients With Tuberculous Meningitis in Indonesia

Arjan van Laarhoven, Sofiati Dian, Carolien Ruesen et al. · The Journal of Infectious Diseases · 2017 · 116 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study

Arjan van Laarhoven, Sofiati Dian, Raúl Aguirre‐Gamboa et al. · The Lancet Infectious Diseases · 2018 · 113 citations · Full text

Medicine, Neurology, Neuroscience +10

Improving the microbiological diagnosis of tuberculous meningitis: A prospective, international, multicentre comparison of conventional and modified Ziehl–Neelsen stain, GeneXpert, and culture of cerebrospinal fluid

A Dorothee Heemskerk, Joseph Donovan, Do Dang Anh Thu et al. · Journal of Infection · 2018 · 113 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +14

Double-Blind, Randomized, Placebo-Controlled Phase II Dose-Finding Study To Evaluate High-Dose Rifampin for Tuberculous Meningitis

Sofiati Dian, Vycke Yunivita, Ahmad Rizal Ganiem et al. · Antimicrobial Agents and Chemotherapy · 2018 · 100 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12